Foslinanib Uses, Dosage, Side Effects and more
Foslinanib is under investigation in clinical trial NCT03600233 (Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors).
| Trade Name | Foslinanib |
| Generic | Foslinanib |
| Foslinanib Other Names | Foslinanib, Trx-818 free acid |
| Type | |
| Formula | C16H13FNO6P |
| Weight | Average: 365.253 Monoisotopic: 365.046452304 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
